XOMA Corporation 8.375% Perpetual Preferred Stock

XOMA Corporation 8.375% Perpetual Preferred Stock is a type of preferred equity that offers investors a fixed dividend yield of 8.375%. This financial instrument is issued by XOMA Corporation, a biotechnology company specializing in the discovery and development of novel antibody therapeutics. The perpetual nature of this preferred stock indicates that it does not have a maturity date, allowing it to exist indefinitely, which is advantageous for investors seeking regular income streams over an extended period. The primary function of this asset is to provide a stable and predictable income, appealing to institutions or individuals seeking lower volatility compared to common stock. Additionally, preferred stockholders typically have precedence over common shareholders regarding dividend payments and asset distribution in the event of liquidation, although they generally lack voting rights. In the financial market, this perpetual preferred stock plays a vital role in balancing portfolios with fixed-income characteristics, often drawing interest from those who prioritize income over capital appreciation in industries related to biotechnology and pharmaceuticals.